Press Release: Shuwen : Shuwen Biotech Announce CE Mark of qPCR Assay for ERBB2 Expression

CercaTest ERBB2 Assay and MammaTyper® may serve as novel companion diagnostics for anti-HER2 therapies targeting HER2-low cancer. BERLIN, GERMANY, April 27, 2022 /⁨EINPresswire.com⁩/ -- Shuwen Biotech, an integrated in vitro diagnostic company with ...